# FLUDEOXYGLUCOSE F18
> **ANDA203246** · Abbreviated New Drug Application (Generic) · Sponsor: UNIV TX MD ANDERSON · Approved 2014-01-13
## Drug
- **FDA Application Number:** ANDA203246
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FLUDEOXYGLUCOSE F18
- **Generic name:** FLUDEOXYGLUCOSE F18
- **Active ingredients:** FLUDEOXYGLUCOSE F-18
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** UNIV TX MD ANDERSON
- **Manufacturer:** The University of Texas MD Anderson Cancer Center
- **First approval:** 2014-01-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203246)
---
*MORVS · CC0 1.0*